000			01516 a2200421 4500
005			20250514065825.0
264		0	_c20040122
008			200401s 0 0 eng d
022			_a0268-3369
024	7		_a10.1038/sj.bmt.1704032 _2doi
040			_aNLM _beng _cNLM
100	1		_aSuratt, B T
245	0	0	_aInterferon-gamma for delayed pulmonary toxicity syndrome resistant to steroids. _h[electronic resource]
260			_bBone marrow transplantation _cMay 2003
300			_a939-41 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdrenal Cortex Hormones _xadverse effects
650	0	4	_aAntineoplastic Agents, Alkylating _xadverse effects
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCarmustine _xadverse effects
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInterferon-gamma _xtherapeutic use
650	0	4	_aLung _xdrug effects
650	0	4	_aMiddle Aged
650	0	4	_aPulmonary Fibrosis _xchemically induced
650	0	4	_aRespiratory Function Tests
650	0	4	_aSyndrome
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aLynch, D A
700	1		_aCool, C D
700	1		_aJones, R B
700	1		_aBrown, K K
773	0		_tBone marrow transplantation _gvol. 31 _gno. 10 _gp. 939-41
856	4	0	_uhttps://doi.org/10.1038/sj.bmt.1704032 _zAvailable from publisher's website
999			_c12537046 _d12537046